🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-05
Trial ID
NCT00522249
Treatments Being Tested
This multicenter, observational study will evaluate the efficacy and safety...
Status
Completed
Location
Clinical Center of Serbia; Institute For Pulmology
Start Date
2013-05
Trial ID
NCT01836133
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University of Colorado Cancer Center at UC Health Sciences Center
Start Date
2007-06-25
Trial ID
NCT00547105
This 4 arm study in patients with advanced Stage IIIb/IV non-small cell can...
Status
Terminated
Location
Tower Cancer Research Foundation
Start Date
2008-11-10
Trial ID
NCT00760929
Treatments Being Tested
The goal of the study is to find the best dose of pacritinib when given in ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-05-18
Trial ID
NCT02342353
Treatments Being Tested
This study will offer a safe treatment for patients with relapsing recurrin...
Status
Completed
Location
Lenox Hill Brain Tumor Center
Start Date
2006-03
Trial ID
NCT00301418
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2007-01
Trial ID
NCT00470535
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-06
Trial ID
NCT00495872
Treatments Being Tested
This study will evaluate the safety, preliminary efficacy, and pharmacokine...
Status
Terminated
Location
Multiple Locations
Start Date
2014-10-16
Trial ID
NCT02206763
Treatments Being Tested
The current trial "A Phase I/II study of Erlotinib +/- Tivozanib as initial...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01728181
Treatments Being Tested